Ledger entry · candidate

Varenicline → Drug hypersensitivity — Audit-grade candidate (scan)

Drug: varenicline · AE: Drug hypersensitivity

Discovered via single-drug scan of varenicline. PRR = 3.20 (95% CI 2.99–3.43), n = 787 cases. Pre-reg locked at submission time.

Disproportionality

Top reactions in cohort

MedDRA PTn
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.